Lendalizumab (Anti-Complement C5)
Lendalizumab (Anti-Complement C5) is a proprietary antibody that targets the complement protein C5a with potential immunomodulating and anti-inflammatory activities. MW : 146.02 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2847 |
Sku # | A2847-1mg |
Pricing | 1mg, $539.00 |